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In this work, the possibility of incorporating proteins into calcium phosphate (Ca-P) coatings, prepared on the surface of starch
polymeric biomaterials by means of a biomimetic route, was investigated. The morphology, chemical composition and crystallinity of Ca-
P coatings was assessed and related to the incorporation of the studied biomolecules. For that, bovine serum albumin (BSA) and a-
amylase were added in concentrations of 1 mg/ml to simulated body fluid (SBF) solutions, being both added at the nucleation or growth
stages of the biomimetic coating process. A biodegradable blend of corn starch/ethylene vinyl alcohol (SEVA-C) was used as substrate
and bioactive glass (45S5 BioglassR) was used as the nucleating agent. The obtained Ca-P coatings were characterised by scanning
electron microscopy (SEM), energy dispersive spectroscopy (EDS), Fourier transform infrared spectroscopy using an attenuated
reflectance device (FTIR-ATR) and thin-film X-ray diffraction (TF-XRD). Additionally, to evaluate the activity of the incorporated
enzyme and the stability of the Ca-P films, coated samples were immersed in an SBF solution for different periods of time. The enzyme
activity was measured and the morphology of the coating examined by SEM. The results obtained showed that the presence of protein
molecules, at the nucleation or growth stages, lead to the formation of a dense Ca-P film presenting different morphologies that were
different of the selected coating conditions. FTIR-ATR analysis detected the presence of carbonate and phosphate groups on the Ca-P
layer, indicating the formation of a coating similar to the mineral component of vertebrates bone tissue. When proteins were added, amide
I and amide II bands, characteristic groups of protein molecules, were also detected, revealing the efficient incorporation of these
biomolecules into the Ca-P coatings.
Ca-P coatings, with a-amylase incorporated at the nucleation stage, showed no degradation of the film after incubation in SBF for 28
days. The release of increasing concentration of reducing sugars with degradation time revealed that a-amylase was efficiently incorporated
in the coating remaining active throughout the coating preparation. This can be a strategy that will allow, in addition of conferring
osteoconductive properties to biodegradable polymers, also simultaneously tailoring their degradation kinetics.
D 2005 Elsevier B.V. All rights reserved.
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Hydroxyapatite (HA) has been often designated as an
osteoconductive material [1]. However, one common prob-
lem of ceramics, intended for load-bearing clinical applica-0928-4931/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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E-mail address: hazevedo@dep.uminho.pt (H.S. Azevedo).tions, is their poor mechanical properties, such as low
bending strength and brittle nature combined with low
values of fracture toughness [2,3]. On the basis of these
findings, adaptative interface functionalities were set as a
target, keeping in mind that they should not compromise
either chemical or physical bulk properties, and must
simultaneously improve the tissue integration. This would
open up the possibility of using non-bioactive materials
including metals and non-metals that have the necessary
strength and toughness to act as bone-bonding implanting C 25 (2005) 169–179
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as a coating material on a substrate that will ensure the
biofunctionality.
In the last few years, coating orthopaedic implants with
calcium phosphates (Ca-P) have been investigated, being
proposed as a rather successful approach [4–7]. However,
most of the available and common methods for producing
adequate Ca-P coatings, such as the plasma-spraying
technique, are difficult to control on what concerns to the
calcium phosphate (Ca-P) layer composition, degree of
crystallinity and capability for strong adhesion to the
substrates [4,6,8,9]. Generally, these techniques need
temperatures of more than 500 8C, which result in the
degradation of HA to various calcium phosphate phases
[10]. HA properties will tend to differ in chemical
composition, in crystal structure as number of defects of
apatite crystals, and/or in the crystallite sizes [11]. Fur-
thermore, techniques that involve high temperatures are
unsuitable for coating polymeric biomaterials and do not
allow for the incorporation of bioactive agents into the
coating.
To overcome the above-mentioned disadvantages, a
biomimetic methodology, adapted from Kokubo et al.
[11], has been used in our research group to produce Ca-P
coatings on the surface of starch-based biomaterials [12–19]
without requiring the use of high processing temperatures.
Bone growth into HA-coated implants is not always
satisfactory. In fact, there is still a need for improvements
regarding the induction of bone formation at the implanta-
tion site. There are indications [20] that the ion release from
Ca-P coatings, as well as the composition and topography of
the Ca-P layer, may indirectly affect cellular pathways like
attachment and proliferation. These bioprocesses are
involved in bone integration through altered ligand-cell
receptor affinities, varied calcium and pH-dependent
enzyme kinetics, and a compositionally or structurally
altered extracellular matrix protein environment [21,22].
For the successful application of these methodologies, there
is the need to understand the integration process of newly
formed bone as well as the calcification at HA–bone
interface, so far could not be fully elucidated.
Mineralisation of bone is a highly organised process
controlled by many kinds of modulators. These modulators
may affect the nucleation and growth of the mineral phases.
Several proteins have been identified to have the ability to
induce bone formation, including the well-known bone
morphogenetic proteins (BMPs) [23–27]. The functional
groups of these biomolecules are thought to play a major
role in inducing bone formation and binding to bone
minerals, thus affecting a uniquely strong interface.
The use of nature inspired methods, such as biomimetic
coatings, presents the advantage of using physiological
conditions, like mild temperature and pH. This in turn
allows for incorporating bioactive species without compro-
mising the performance of the coatings and to improve the
functionality of the inorganic layer at the implantationinterface. Several authors [28–41] have proposed models to
explain the nucleation and formation of Ca-P layers in the
presence of biomolecules. Proteins, enzymes, bone related
proteins, mixtures and serum protein models, as other
biologically important molecules, have been investigated
for this purpose.
In this work, the possibility of incorporating proteins and
enzymes at different stages of the preparation of Ca-P
coatings by a biomimetic methodology was studied. Serum
albumin was used as a model protein due to its concen-
tration in the blood plasma, binding and diffusion proper-
ties. On the other hand, a-amylase was exploited in terms of
enzymatic properties, ability to interact with starch-based
materials and tailor their degradation kinetics for a specific
application. The influence of protein supplementation on the
morphology, chemical composition, crystallinity and stabil-
ity of the Ca-P coatings was investigated for both the
nucleation and the growth stages. The adequacy of the
selected procedure on the incorporation efficiency and
activity of the biomolecules was also evaluated. In this
case, the aim was to investigate the carrier potential of the
Ca-P coatings for sustained release applications.2. Experimental part
2.1. Materials
The material used in this study was a biodegradable
polymeric blend of corn starch with poly(ethylene-vinyl
alcohol) copolymer (50/50 wt.%), designated by SEVA-C.
Using conventional injection moulding technology (Klock-
ner-Ferromatik Desma FM20), 24 mm2 cross-section
dumb-bell ASTM tensile samples were produced. Further
details on the material processing and respective mechanical
properties can be found elsewhere [42,43].
A bioactive glass (45S5 BioglassR) with the following
composition: 45 SiO2, 24.5 CaO, 24.5 Na2O and 6.0 P2O5
in wt.%, was supplied by US Biomaterials Corp. (Florida,
USA). This glass powder was used as precursor for calcium
phosphate film deposition and, by laser scattering analysis
(Coulter LS 100 particle size analyser), particle size was
found to be lower than 20 Am.
Bovine serum albumin (BSA, Fraction V) was obtained
from Sigma (St. Louis, USA) and a-amylase, from Bacillus
amyloliquefaciens, was gently supplied by Genencor
International (Rochester, NY, USA).
2.2. Preparation of Ca-P coatings—adapted biomimetic
route
The procedure used to produce Ca-P coating was based
on the methodology previously developed by Abe et al. [11]
and further adapted by Reis et al. [12,19]. Prior to the
coating process, SEVA-C samples were sterilized by ethyl-
ene oxide in optimized conditions previously described [44].
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solution (70%, v/v) and allowed to dry inside the laminar
flow cabinet. Protein and enzyme solutions were reconsti-
tuted to a final concentration of 1 mg/ml in simulated body
fluid (SBF) solution (pH 7.4) presenting ionic concentra-
tions similar to human plasma. SBF and protein solutions
were sterilized by filtration (0.20 Am pore). All the
subsequent procedures were performed under sterile con-
ditions in a vertical flow laminar cabinet to avoid samples
and solutions contamination. The SEVA-C biomaterials
were rolled on a bed of wet BioglassR (45S5) particles and
immediately immersed in 15 ml of 1.0 SBF solution.
Incubation was allowed for 7 days at 37 8C for Ca-P nuclei
formation (nucleation stage). Following this period, samples
were removed from the incubation solution, immersed in a
1.5 SBF solution and further incubated for 7 and 14 days in
order to enable Ca-P nuclei growth (growth stage). SEVA-C
samples were also incubated in SBF solution containing
BSA or a-amylase as described in Table 1.
After each immersion period, samples were taken from
the incubation solution, rinsed with distilled water, dried at
room temperature and stored before surface analysis.
Incubation solutions were stored at 4 8C for element con-
centration and enzyme activity determinations.
2.3. Characterisation of Ca-P coatings
2.3.1. SEM and EDS
Ca-P coatings morphology and presence of calcium,
phosphorous and silicon elements on the coating surface
were analysed before and after soaking in SBF, for the
different experimental conditions and controls. This was
carried out using scanning electron microscopy (SEM)
coupled to energy dispersive spectroscopy (EDS) equipment
(Leica Cambridge S360, UK). Previously to EDS and SEM
analysis, sample surfaces were carbon coated (Fisons
Instruments, Evaporation PSU CA508, UK) and gold
sputtered (Fisons Instruments, Sputter Coater SC502, UK),
respectively.
2.3.2. FTIR-ATR
The chemical structure of the coatings formed on the
surface of SEVA-C under the different conditions studied
was analysed by Fourier transform infrared spectroscopy
with attenuated reflectance (FTIR-ATR). All condition
spectra were recorded using at least 64 scans and 2 cm1Table 1
Solution compositions and respective immersion conditions for the
incorporation of biomolecules into the biomimetic coatings
Condition Nucleation stage Growth stage
A (Control) 1.0 SBF 1.5 SBF
B 1.0 SBF+BSA (1 g/l) 1.5 SBF
C 1.0 SBF+a-amylase (1 g/l) 1.5 SBF
D 1.0 SBF 1.5 SBF+BSA (1 g/l)
E 1.0 SBF 1.5 SBF+a-amylase (1 g/l)resolution in an FTIR spectrophotometer (Perkin-Elmer
1600 Series, USA) and using a single reflection ATR system
(MKII Golden Gatek, Specac, UK).
2.3.3. TF-XRD
Thin-film X-ray diffraction (TF-XRD, Philips X’Pert
MPD, The Netherlands) was used to characterise the
crystalline/amorphous nature of the films and to identify
any crystalline phases present after immersion in SBF
(results were compared to non-immersed controls). The data
collection was performed by 2h scan method with 18 as
incident beam angle using CuKa X-ray line and a scan
speed of 0.058/min in 2h.
2.3.4. Solution analysis
Different sample solutions were analysed in order to
determine the concentrations of calcium, phosphorus,
silicon and sodium elements as a function of the
immersion time. The element concentrations were meas-
ured by inductively coupled plasma optical emission
spectroscopy (ICP-OES, JY 70 plus, Jobin Yvon, France).
Duplicate samples were analysed for each condition and
immersion time. Incubation solutions were also analysed
to measure the activity of a-amylase during the coating
preparation. The dinitrosalicylic acid (DNS) method [45]
was used to measure the concentration of reducing sugars
produced as a result of starch hydrolysis. Adequate
controls were prepared for assuring non-enzymatic mate-
rial degradation effect.
2.3.5. Stability of Ca-P coatings and evaluation of
a-amylase activity
To evaluate the stability of the produced coatings, as well
the activity of the incorporated enzyme, coated samples,
prepared according with condition C (Table 1), were
incubated in 1.0 SBF (pH 7.4) at 37 8C for 7, 14 and 28
days. As described, after each degradation period the
morphology of the coatings was analysed by SEM.
Furthermore, enzyme activity, as function of incubation
time, was determined by measuring the concentration of
reducing sugars released into solution.3. Results
3.1. TF-XRD analysis
In Fig. 1a, the TF-XRD patterns of SEVA-C surface after
14 days of immersion in the SBF (control) can be observed.
By using non-immersed samples as controls surfaces, the
characteristic main peaks of HA were evidenced and
afterwards, confirmed by matching with the XRD spectra
showing the standard HA pattern (JCPDS 9-432). Never-
theless, it seems that the apatite formed is mainly
amorphous, as it was detected in other types of biomimetic
coatings [15,19].
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Fig. 1. TF-XRD patterns of the Ca-P coatings produced on SEVA-C surface after the nucleation stage (7 days), and growth stage (7 and 14 days) for conditions
A (a) and E (b).
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growth stage), after 14 days in SBF, two diffraction peaks
that can be assigned to an apatite-like phase (ASTM JCPDS
9-432) (Fig. 1b) was observed. However, again, the film
was rather amorphous.
The lower intensity of the diffraction of the apatite phase
indicates that in the nucleation stage a much thinner apatite
layer was formed on the specimen surface. Also, this fact
was observed for the other conditions. Studies have been
relating the presence of proteins with a lower crystallinity of
minerals, such as apatite in bone [46].
3.2. FTIR-ATR analysis
In the control (condition A) after soaking in SBF for 7
days in the growth stage, the FTIR-ATR spectrum displays
reflectance bands associated with apatitic phosphate group
(the group band at 1018 cm1), and bands associated with
carbonate substitution (the group band at 1418 cm1). As
the soaking time increases these bands were observed to be
more intense (Fig. 2a).
When a-amylase and BSA were added to the SBF
solution, either in nucleation or growth stages, chemical
changes were observed in the IR spectra at 1650 cm1. This
can be ascribed to the amide I band that represents the
stretching vibrations of CMO bonds in the backbone of the
protein (Fig. 2b and c) [47]. In turn, obtained results could
indicate adsorption of proteins on the surface of the
substrate. Furthermore, in conditions D and E, after 7 days
and during the growth stage in SBF solution, FT-IR spectra
shows bands centered at 1650 and 1542 cm1 that can be
attributed to amide I and amide II, respectively (Fig. 2c)
[47]. The amide II band arises from the combination of C–N
stretching and N–H bending vibrations of the proteinbackbone [47], which observation confirms again the
incorporation of biomolecules into the coating.
Moreover, carbonate and phosphate bands, located,
respectively at 1418 and 1020 cm1, were observed in the
collected spectra. These results confirm that the apatite layer
formed on the surface of this polymer is a carbonated apatite
mineral similar to the major mineral component of bone
[48].
3.3. SEM and EDS analysis
Fig. 3 shows the SEM micrographs of the calcium
phosphate coatings onto SEVA-C surface before and after
soaking in SBF solution for different conditions. The
observed calcium phosphate coatings were observed as
uniform layers covering SEVA-C substrate for all the
studied conditions.
However, some significant differences were found
between all conditions. When BSA and a-amylase were
added to the SBF solution in the nucleation stage
(conditions B and C), only the formation of apatite nuclei
was observed, meaning that increasing soaking time in SBF
did not promote growth of the Ca-P layer (please see Fig. 3c
and d). Quite the opposite was observed when the same
biomolecules were added in the SBF solution during the
growth stage (conditions D and E—Fig. 3e and f). For
conditions D and E, in the first 7 days in the growth stage,
only the formation of apatite nuclei was possible to observe
on the SEVA-C surface. Furthermore, for condition E, as the
soaking time increased, the Ca-P film becomes denser and
compact.
The incorporation of BSA was found to change the
morphology of the coating both in the nucleation and
growth stage: the size of Ca-P nuclei did not increase and
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Fig. 2. FTIR-ATR spectra of the Ca-P coatings produced on SEVA-C surface before coating and after nucleation and growth stages for conditions A (a), B (b)
and D (c).
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immersion time. Regarding the presence of a-amylase in
the growth stage, the effect was the opposite. With
increasing soaking time, Ca-P nuclei grew in size by
consuming the calcium and phosphorus ions from the SBF
solution, resulting in turn in the formation of a denser Ca-
P film (Fig. 3f). This behaviour was also found by other
authors [49].
EDS analysis (data not shown) confirmed the presence of
silicon (Si) element as well as the calcium (Ca) and
phosphorus (P) signal elements after 7 days in the nucleation
stage. In the growth stage, only P and Ca signals were
detected. Herein, signal intensity significantly increased
indicating in turn density increase of the Ca-P coating.3.4. ICP analysis
The variation of Ca, P, Si and Na concentrations in
conditions D and E are shown in Fig. 4 as a function of
immersion time in SBF solution for nucleation and growth
stages.
In the nucleation stage of both conditions, an accentuated
increase of Si and Na concentrations was observed, being
attributed to the dissolution of the bioactive glass particles.
Also, the decrease in the Ca and P concentration in the
solution in the first immersion days confirms the nucleation
of Ca-P layer on the immersed sample.
Moreover, the water uptake capability of SEVA-C
allowed the material to absorb higher quantities of Ca2+
(a) (b)
(c) (d)
(e) (f)
Fig. 3. SEM micrographs of the Ca-P coatings produced on the surfaces of SEVA-C before coating (a), and after 14 days in SBF (growth stage). (b) Control, (c)
BSA and (d) a-amylase added in the nucleation stage, (e) BSA and (f) a-amylase added in the growth stage.
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3- ions from the solution. In the growth stage, for
both conditions, there was a large number of Ca-P nuclei
formed that induce a spontaneous growth of the Ca-P film—
consuming Ca2+ and PO4
3- ions from SBF solution. As the
immersion time increases, Ca and P concentrations
decreased gradually probably due to the Ca-P formation
by consuming the calcium and phosphate ions in SBF.
However, in condition D, in the first 7 days in the growth
stage, there was a steep decrease in the calcium and
phosphorus concentrations, as it is shown in Fig. 4a. As a
result, the calcium phosphate nuclei formed in this condition
did not grow due to a quick consumption of such species
from SBF (Fig. 3e).3.5. Stability of Ca-P coatings and evaluation of a-amylase
activity
In vitro dissolution of Ca-P materials depends on their
composition, surface area, surface topography, micro- and
macroporosities, and crystallinity [50]. Independently from
the degree of crystallinity, all Ca-P coatings will dissolve or
degrade to some extent. The amorphous phases are expected
to dissolve first than crystalline compounds. There is,
therefore, the possibility to produce a Ca-P coating with
the biodegradation rate desired for particular applications,
by varying the crystallinity, composition and microstructure
of the coating.
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according to condition C (incorporation of a-amylase at
nucleation stage) was examined by SEM. The coating
morphology after immersion in 1.0 SBF (Fig. 5) shows that
the typical morphology of Ca-P coatings remained
unchanged even after 28 days of immersion. Liu et al.
[49,51] reported that the dissolution of Ca-P coatings on the
surface of titanium implants was reduced when BSA was
incorporated in the coating. It was postulated that the protein
was able to reduce the release of Ca from the coating and to
enhance the adhesion between the coating and titanium.
Further studies should investigate the effect of protein
incorporation at the nucleation and growth stages on the
dissolution rate of the Ca-P coating by measuring the release
of calcium and phosphorus elements, as well as the protein.
Also, monitoring changes on the crystallinity, composition
and thickness of the film would be interesting.
a-Amylase is an endo-specific enzyme which catalyses
the hydrolysis of a-1,4-glycosidic linkages of starch to
maltose and dextrins, reducing the molecular size of starch.
The activity of a-amylase may be detected by measuring the
soluble reducing ends released into the solution as a result of
starch hydrolysis. To assess if a-amylase remained active
after being incorporated in Ca-P coating, coated samples(a)
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Fig. 4. Evolution of Ca, P, Si and Na concentrations in SBF as function of
immersion time in the nucleation and growth stages for conditions D (a) and
E (b).(prepared according with condition C) were immersed in 1.0
SBF and incubated at 37 8C for different periods of time.
Analysing the results presented in Fig. 6, it is possible to
observe that the concentration of reducing sugars increased
with incubation time, indicating that the methodology used
to produce Ca-P coatings did not have a denaturation effect
on the enzyme activity and that the enzyme remained active
to further catalyse the hydrolysis of starch. This demon-
strates that a-amylase was efficiently incorporated in the
coating and only Ca-P dissolution might trigger the release
of the enzyme.4. Discussion
With the biomimetic coating methodology it was
possible to incorporate biomolecules, such as BSA and a-
amylase. However, there were some considerable differ-
ences between the incorporation of biomolecules in the
nucleation and growth stage.
The effect of proteins on the formation of Ca-P coatings
has been subjected to an extensive research [28,29,38,51–
55]. Most of these studies aimed to investigate the possible
role of plasma proteins on the formation of an apatite layer
in vivo, but few had exploited the possibility of incorporat-
ing therapeutic agents into Ca-P films to develop a delivery
system for the sustained release of biomolecules.
Proteins are highly surface-active molecules due to their
amphiphilic properties [56]. Hence, they can interact with
any encounter interface, generally leading to adsorption of
the proteins [57,58] that is responsible for a range of initial
and fate-determining interactions [59]. Albumin, specifi-
cally, was selected for this study due to its high concen-
tration in the blood serum, favourable diffusion coefficient
and ability to bind other molecules [60,61]. On the other
hand, a-amylase was used as appropriate to study enzymatic
properties and due to its ability to interact with starch-based
materials [62].
It was found that the adsorption of proteins on the
mineral surface can alter the nucleation and growth process,
acting as promoters or inhibitors of biomineralisation,
depending on the concentration of adsorbed proteins [29].
Combes et al. [29] observed that BSA had two opposite
effects on the growth kinetics of octacalcium phosphate
(OCP) on type I collagen. At concentrations lower than 10
mg/ml, BSA favoured the growth of OCP, whereas at higher
concentrations (up to 60 mg/ml) BSA presented an
inhibitory effect. In the presence of about 1 mg/ml of
BSA, the OCP growth rate was twice higher than in the
absence of BSA. In this study, the concentration of BSA and
a-amylase used was 1 mg/ml and this may explain the fact
that no inhibitory effect was observed when the proteins
were added to the SBF solutions.
It is well known that anionic substances, especially those
containing phosphate or phosphonate groups, are quite
efficient in regulating calcium phosphate crystallisation
(a) (b)
(c)
Fig. 5. SEM micrographs of the Ca-P coatings, produced according with the conditions described for condition C, after incubation in 1.0 SBF at 37 8C for 7 (a),
14 (b) and 28 (c) days.
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isoelectric points of BSA and a-amylase are 4.7 and 5.7,
respectively, which means, that at the physiological pH
(7.4), these proteins are negatively charged and tend
spontaneous to bind positive ions like Ca2+ ones present
in the environment solution [58]. Furthermore, serum
albumin and most a-amylases contain calcium-binding sites
[63,64]. The presence of these cations may affect the0 5 10 15 20 25 30
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Fig. 6. Concentration of reducing sugars produced during the incubation of
coated SEVA-C samples (with a-amylase incorporated in the nucleation
stage—condition C) in 1.0 SBF (pH 7.4) at 37 8C for different periods of
time.conformational stability of these proteins and consequently
their adsorption and activity profile. These phenomena
would, therefore, strongly affect Ca2+ ions availability for
the formation and growth of Ca-P nuclei [51].
It has been suggested that there are two general types of
Ca-P coatings inhibitors: those affecting nucleation and
those affecting growth, since both these mechanisms are
quite different. A protein may act in different ways against
crystal nucleation and growth. The effect of protein
adsorption in the nucleation stage is complex since protein
adsorption may occur on the substrate and on the Ca-P
nuclei. Combes and Rey [28] proposed a model, based on
experimental data and thermodynamic considerations,
which describe the influence of protein adsorption on the
nucleation and growth processes during formation of Ca-P
coatings. The addition of proteins at different stages of the
preparation of Ca-P coatings is expected, therefore, to
produce coatings with distinct characteristics.
The results obtained in the present work show differ-
ences on the properties of the developed coatings namely
on their composition and morphology. FTIR analyses
confirmed the formation of a calcium phosphate layer on
the surface of the polymeric material in all the conditions
studied, as detected by the presence of phosphate and
carbonate groups. In particular, when BSA was incorpo-
rated either in the nucleation or growth stage, the
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delayed. This effect was more pronounced in condition D,
as it was observed by SEM. This can be interpreted in
terms of interactions between the protein with the bioactive
glass particles (nucleating agent) and with the starch
polymeric material (substrate). It is possible that in
condition B such interactions might have occurred, where
there is a competition between the substrate and the
nucleating agent. In this situation, BSA might have
adsorbed on the surface of SEVA-C and also on Bioglass.
The presence of the protein layer on the glass surface
could reduce or prevent the ionic exchange that must be
established at interface with the substrate. Ducheyne et al.
[39,65] and Wen et al. [66] had observed the same
behaviour. As result, in condition B, the formation of Ca-P
film was delayed, once it was only observed in the growth
stage and after 14 days (please see Fig. 3c). Moreover, in
the FTIR spectra, the intensity of the characteristics bands
of proteins was not so intense, which may indicate no
adsorption of BSA on the SEVA-C and can suggest its
adsorption onto the glass surface.
The ICP analysis provided additional information on
the effect of the incorporation of the two biomolecules on
the formation of the biomimetic coating. The dissolution,
ion exchange, and precipitation reactions were observed
even in the presence of BSA and a-amylase, changing
only the reaction rate. So, when BSA is adsorbed on the
surface of SEVA-C, the concentration of Ca in the SBF
solution decreases significantly. It is suggested that BSA
is capturing the Ca ions from the SBF solution (confirmed
by ICP analysis). These ions may also act as bridges
between the negatively charged proteins and the hydroxyl
groups pre-exposed on the SEVA-C surface. In condition
D, the accentuated decrease of Ca from the solution may
be due to the competitive binding of calcium ions to the
molecule of albumin and therefore the film did not grow
after 14 days, only the formation of Ca-P nuclei film had
occurred. This may be related with the adsorption of BSA
on the Ca-P nucleus film and, as result, they cannot be
active for crystal growth. Since there is an accentuated
decrease of calcium from the solution (see Fig. 4a), the
nucleus can grow in number but not in size. Such results
had been found by Combes et al. [29] who explained that
the adsorption of albumin decreases the interfacial energy
of the Ca-P nuclei and therefore stabilizes nuclei with
smaller radii. The formation of such small nuclei is
facilitated and their number can thus increase rapidly.
The different coating morphologies observed for BSA
and a-amylase incorporation may be related with their
amino acid composition, conformational structure and
adsorption behaviour. This will influence the type and
number of amino acids, as well as their orientation, which
will be exposed at the surface. These functional groups may
be involved in the initial stages of mineral formation
through complexation of calcium cations, which in turn
attract phosphate anions.It was also reported that, when present in solution,
some proteins were capable of inhibiting the formation of
calcium phosphates, either by binding calcium or phos-
phate or by adsorbing onto apatite surfaces, thus blocking
active growth sites. The immobilisation of those proteins
(adsorbed as a film or bound to a support material)
showed, on the contrary, to initiate mineral formation
[30,67]. It is believed that, when the protein is adsorbed,
it will complex with calcium at the surface, inducing
precipitation, whereas the complexation in solution retards
the precipitation. Campbell and Nancollas [31] inves-
tigated the ability of various salivary proteins to miner-
alise hydroxyapatite, when immobilised as films, and
found that salivary amylase was shown to be the most
active protein in inducing the nucleation and growth of
calcium phosphate. This may confirm the results found
with a-amylase, although in the present study the proteins
were used in solution. It should be considered, however,
that there are strong evidences that a-amylase had
adsorbed on the material surface, since it was detected
the production of reducing sugars during the various
stages of incubation (data not shown). The hydrolysis of
starch is only possible by the pre-adsorption of the
enzyme to the substrate. It is well known that the
adsorption of polysaccharide-degrading enzymes to insolu-
ble substrates is a prerequisite step before catalysis and
these enzymes exhibit high affinity and bind specifically
to their substrates [68].
Different behaviours have been reported in the liter-
ature concerning the effect of proteins on the nucleation
and inhibition of hydroxyapatite formation. This is mainly
due to the diversity of experimental systems used, which
makes it difficult to find an overall conclusion. Having
into account the various interactions that can be estab-
lished between the proteins, the substrate and the various
ions present in solution during the nucleation and growth
stages, the mineralisation process in the presence of
biological molecules can be considered a rather complex
subject. Consequently, more sophisticated analysis techni-
ques are needed to better understand the multiple events
occurring in the process. Even though, these results
suggest that it is possible to tailor the properties of the
coatings. Porosity, mechanical properties, dissolution rate,
release profile and cellular response are also expected to
be affected by the selection of proper proteins and its
incorporation at different stages of the coating preparation.5. Conclusion
In this work, BSA and a-amylase were successfully
incorporated into a Ca-P coating on the surface of starch-
based polymer using a biomimetic technique. The addition
of proteins with distinct characteristics to the SBF
solutions, at different stages of the Ca-P coating formation,
affected the composition, structure and morphology of the
H.S. Azevedo et al. / Materials Science and Engineering C 25 (2005) 169–179178obtained Ca-P layer. This enables the possibility of
tailoring the properties of biomaterials by incorporating
specific proteins at different compositions and combina-
tions into Ca-P coatings. Furthermore, this methodology
proved to be able to preserve the activities of enzymes.
Herein indicating the carrier potential of calcium phosphate
coatings for the sustained delivery of other bioactive
agents. The efficient incorporation of active a-amylase
into Ca-P coatings may be used, for instance, as a method
to control the degradation rate of starch-based biomaterials.
These results enable definitively for the new perspective of
adding osteoinductive proteins or growth factors into
biomimetic coatings, for inducing bone growth on the
implant surroundings.
Further studies should be carried out to investigate in
more detail the dissolution of Ca-P coatings, with or without
proteins incorporated at the nucleation or growth stages, and
the release profile of the entrapped proteins. Cell studies
should also investigate the effect of the resultant Ca-P
coating in the morphology, adhesiveness, proliferation and
differentiation of bone-like cells.Acknowledgement
This work was partially supported by Portuguese
Foundation for Science and Technology (FCT) and was
performed within the framework of the project BIOLEARN
(POCTI/CTM/38803/2001) through funds from the POCTI
and/or FEDER Programmes. H. S. Azevedo would also like
to thank FCT for providing her a postdoctoral scholarship
(Grant SFRH/BPD/5744/2001).References
[1] L.L. Hench, Biomaterials 19 (1998) 1419.
[2] W.P. Cao, L.L. Hench, Ceramics International 22 (1996) 493.
[3] F. Mestral, R.A.L. Drew, Journal of the European Ceramic Society 5
(1989) 47.
[4] K.A. Gross, C.C. Berndt, Journal of Biomedical Materials Research
39 (1998) 580.
[5] L. Cle`ries, J.M. Fernandez-Pradas, J.L. Morenza, Biomaterials 21
(2000) 1861.
[6] M. Wei, A.J. Ruys, M.V. Swain, S.H. Kim, B.K. Milthorpe, C.C.
Sorrell, Journal of Materials Science. Materials in Medicine 10 (1999)
401.
[7] K. Yamashita, T. Arashi, K. Kitagaki, S. Yamada, T. Umegaki,
K. Ogawa, Journal of the American Ceramic Society 77 (1994) 2401.
[8] K. Hayashi, T. Inadome, T. Mashima, Y. Sugioka, Journal of
Biomedical Materials Research 27 (1993) 557.
[9] M. Tanahashi, T. Yao, T. Kokubo, M. Minoda, T. Miyamoto,
T. Nakamura, T. Yamamuro, Journal of Biomedical Materials
Research 29 (1995) 349.
[10] F. Fazan, P.M. Marquis, Journal of Materials Science. Materials in
Medicine 11 (2000) 787.
[11] Y. Abe, T. Kokubo, T. Yamamuro, Journal of Materials Science.
Materials in Medicine 1 (1990) 233.
[12] A.L. Oliveira, C. Elvira, R.L. Reis, B. Vazquez, J. San Roman, Journal
of Materials Science. Materials in Medicine 10 (1999) 827.[13] A.L. Oliveira, C.M. Alves, R.L. Reis, Journal of Materials Science.
Materials in Medicine 13 (2002) 1181.
[14] A.L. Oliveira, I.B. Leonor, C. Elvira, M.C. Azevedo, I. Pashkuleva,
R.L. Reis, in: R.L. Reis, D. Cohn (Eds.), Polymer Based Systems on
Tissue Engineering, Replacement and Regeneration, Kluwer Press,
Drodercht, 2002, p. 183.
[15] A.L. Oliveira, M.E. Gomes, P.B. Malafaya, R.L. Reis, in: B. Ben-
Nissan, D. Sher, W. Walsh (Eds.), Bioceramics, 15, Trans Tech
Publications, Zurich, 2003, p. 101.
[16] A.L. Oliveira, I.B. Leonor, P.B. Malafaya, C.M. Alves, H.S. Azevedo,
R.L. Reis, in: B. Ben-Nissan, D. Sher, W. Walsh (Eds.), Bioceramics,
15, Trans Tech Publications, Zurich, 2003, p. 111.
[17] A.L. Oliveira, J.F. Mano, R.L. Reis, Current Opinion in Solid State
and Materials Science 7 (2003) 309.
[18] A.L. Oliveira, P.B. Malafaya, R.L. Reis, Biomaterials 24 (2003) 2575.
[19] R.L. Reis, A.M. Cunha, M.H. Fernandes, R.N. Correia, Journal of
Materials Science, Materials in Medicine 8 (1997) 897.
[20] P. Ducheyne, Q. Qiu, Biomaterials 20 (1999) 2287.
[21] D.E. MacDonald, F. Betts, M. Stranick, S. Doty, A.L. Boskey, Journal
of Biomedical Materials Research 54 (2001) 480.
[22] E.M. Burke, J.D. Haman, J.J. Weimer, A.B. Cheney, J.M. Rigsbee,
L.C. Lucas, Journal of Biomedical Materials Research 57 (2001) 41.
[23] T. Kaito, A. Myoui, K. Takaoka, N. Saito, M. Nishikawa, N. Tamai,
H. Ohgushi, H. Yoshikawa, Biomaterials 26 (2005) 73.
[24] C.A. Kirker-Head, Advanced Drug Delivery Reviews 43 (2000)
65.
[25] J.R. Lieberman, A. Daluiski, T.A. Einhorn, Journal of Bone and Joint
Surgery. American Volume 84-A (2002) 1032.
[26] Y. Tabata, Tissue Engineering 9 (2003) S5.
[27] L.C. Yeh, M.C. Zavala, J.C. Lee, Journal of Cellular Physiology 190
(2002) 322.
[28] C. Combes, C. Rey, Biomaterials 23 (2002) 2817.
[29] C. Combes, C. Rey, M. Freche, Journal of Materials Science.
Materials in Medicine 10 (1999) 153.
[30] D. Couchourel, C. Escoffier, R. Rohanizadeh, S. Bohic, G. Daculsi,
Y. Fortun, M. Padrines, Journal of Inorganic Biochemistry 73 (1999)
129.
[31] A.A. Campbell, G.H. Nancollas, Colloids and Surfaces 54 (1991) 33.
[32] S.A. Bender, J.D. Bumgardner, M.D. Roach, K. Bessho, J.L. Ong,
Biomaterials 21 (2000) 299.
[33] R. Fujisawa, Y. Kuboki, Biochimica et Biophysica Acta 1075 (1991)
56.
[34] G.K. Hunter, P.V. Hauschka, A.R. Poole, L.C. Rosenberg, H.A.
Goldberg, Biochemical Journal 317 (Pt. 1) (1996) 59.
[35] K.D. Lobel, L.L. Hench, Journal of Biomedical Materials Research 39
(1998) 575.
[36] A. Krajewski, R. Malavolti, A. Piancastelli, Biomaterials 17 (1996)
53.
[37] R.I. Martin, P.W. Brown, Journal of Materials Science. Materials in
Medicine 5 (1994) 96.
[38] J. Mei, R.M. Shelton, P.M. Marquis, Journal of Materials Science.
Materials in Medicine 6 (1995) 703.
[39] H.H. Lu, S.R. Pollack, P. Ducheyne, Journal of Biomedical Materials
Research 54 (2001) 454.
[40] F.H. Shen, Q.L. Feng, C.M. Wang, Journal of Crystal Growth 242
(2002) 239.
[41] J. Xie, C. Riley, K. Chittur, Journal of Biomedical Materials Research
57 (2001) 357.
[42] R.L. Reis, A.M. Cunha, P.S. Allan, M.J. Bevis, Polymers for
Advanced Technologies 7 (1996) 784.
[43] R.L. Reis, A.M. Cunha, in: K.H.J. Buschow, R.W. Cahn, M.C.
Flemings, B. Ilschner, E.J. Kramer, S. Mahajan (Eds.), Biological and
Biomimetic Materials, Pergamon-Elsevier Science, Amsterdam, 2001,
p. 8810.
[44] R.L. Reis, S.C. Mendes, A.M. Cunha, M.J. Bevis, Polymer Interna-
tional 43 (1997) 347.
[45] T.K. Ghose, Pure and Applied Chemistry 59 (1987) 257.
H.S. Azevedo et al. / Materials Science and Engineering C 25 (2005) 169–179 179[46] H.B. Wen, J.R. de Wijn, C.A. van Blitterswijk, K. de Groot, Journal of
Biomedical Materials Research 46 (1999) 245.
[47] J. Xie, C. Riley, M. Kumar, K. Chittur, Biomaterials 23 (2002) 3609.
[48] S. Mann, Biomineralization, Principles and Concepts in Bioinorganic
Materials Chemistry, Oxford University Press, Oxford, 2001.
[49] Y. Liu, M. Stigter, K.d. Groot, P. Layrolle, in: S. Brown, I. Clarke, P.
Williams (Eds.), Bioceramics 14. Trans Tech Publications, Zurich,
2002, p. 157.
[50] R.Z. LeGeros, Clinical Orthopaedics (2002) 81.
[51] Y. Liu, P. Layrolle, J. de Bruijn, C. van Blitterswijk, K. de Groot,
Journal of Biomedical Materials Research 57 (2001) 327.
[52] S. Radin, P. Ducheyne, Journal of Biomedical Materials Research 30
(1996) 273–279.
[53] S. Radin, P. Ducheyne, B. Rothman, A. Conti, Journal of Biomedical
Materials Research 37 (1997) 363.
[54] A. Serro, B. Saramago, Journal of Biomedical Materials Research 49
(2000) 345.
[55] B. Feng, J. Chen, X. Zhang, Biomaterials 23 (2002) 2499.
[56] W. Norde, Advances in Colloid Interface Science 25 (1986) 267.
[57] K. Nakanishi, T. Sakiyama, K. Imamura, Journal of Bioscience and
Bioengineering 91 (2001) 233.
[58] T. Suzawa, H. Shirahama, Advances in Colloid and Interface Science
35 (1991) 139.
[59] C. Mannhalter, Sensors and Actuators. B, Chemical 11 (1993) 273.[60] C. Oehr, Nuclear Instruments and Methods in Physics Research.
Section B, Beam Interactions with Materials and Atoms 208 (2003) 40.
[61] C.R. Jenney, J.M. Anderson, Journal of Biomedical Materials
Research 49 (2000) 435.
[62] H.S. Azevedo, F.M. Gama, R.L. Reis, Biomacromolecules 4 (2003)
1703.
[63] A. Klinger, D. Steinberg, D. Kohavi, M.N. Sela, Journal of
Biomedical Materials Research 36 (1997) 387.
[64] E. Boel, L. Brady, A.M. Brzozowski, Z. Derewenda, G.G. Dodson,
V.J. Jensen, S.B. Petersen, H. Swift, L. Thim, H.F. Woldike,
Biochemistry 29 (1990) 6244.
[65] E.A. Kaufmann, P. Ducheyne, S. Radin, D.A. Bonnell, R. Composto,
Journal of Biomedical Materials Research 52 (2000) 825.
[66] H.B. Wen, J. Moradian-Oldak, J.P. Zhong, D.C. Greenspan, A.G.
Fincham, Journal of Biomedical Materials Research 52 (2000)
762.
[67] P.A. Marques, A.P. Serro, B.J. Saramago, A.C. Fernandes, M.C.
Magalhaes, R.N. Correia, Biomaterials 24 (2003) 451.
[68] A.B. Boraston, B.W. McLean, J.M. Kormos, M. Alam, N.R. Gilkes,
C.A. Haynes, P. Tomme, D.G. Kilburn, R.A.J. Warren, in: H.J.
Gilbert, G.J. Davies, B. Henrissat, B. Svenson (Eds.), Recent
Advances in Carbohydrate Bioengineering, The Royal Society of
Chemistry, Cambridge, 1999, p. 202.
